Interview with presenter at ESC 2021 plenary talk, Prof. Stefan Anker, MD, PhD, about the full results of the EMPEROR-Preserved trial, which affirm that empagliflozin lowers the risk of CVD in patients with heart failure and HFpEF, leading one expert to say this is “a big day for patients living with HFpEF, a big day for heart failure clinicians.”

Also, Dr. J. Stacey Klutts, a medical microbiologist at Rush University, discusses his op-ed in the Tampa Bay Times comparing the Delta variant of SARS-CoV-2 to Gorilla Glue, which went viral.